Pranab K Mukherjee
Overview
Explore the profile of Pranab K Mukherjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
3514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mukherjee P, Nguyen Q, Li J, Zhao S, Christensen S, West G, et al.
bioRxiv
. 2023 Apr;
PMID: 37066202
Background: Fibroblasts play a key role in stricture formation in Crohn's disease (CD) but understanding it's pathogenesis requires a systems-level investigation to uncover new treatment targets. We studied full thickness...
12.
Rieder F, Mukherjee P
J Eur Acad Dermatol Venereol
. 2023 Mar;
37(4):649-650.
PMID: 36924444
No abstract available.
13.
Hammond M, Gamal A, Mukherjee P, Damiani G, McCormick T, Ghannoum M, et al.
Front Microbiol
. 2022 Dec;
13:944365.
PMID: 36452925
Atopic dermatitis (AD) is associated with cutaneous dysbiosis, barrier defects, and immune dysregulation, but the interplay between these factors needs further study. Early-onset barrier dysfunction may facilitate an innate immune...
14.
Lin S, Musso A, Wang J, Mukherjee P, West G, Mao R, et al.
Matrix Biol
. 2022 Sep;
113:1-21.
PMID: 36108990
Objective: Inflammatory bowel diseases (IBD) cause chronic intestinal damage and extracellular matrix (ECM) remodeling. The ECM may play an active role in inflammation by modulating immune cell functions, including cell...
15.
Reid M, Obenaus A, Mukherjee P, Khoutorova L, Roque C, Petasis N, et al.
J Stroke Cerebrovasc Dis
. 2022 Jun;
31(8):106585.
PMID: 35717719
Objective: We tested the hypothesis that blocking pro-inflammatory platelet-activating factor receptor (PAFR) with LAU-0901 (LAU) plus administering a selected docosanoid, aspirin-triggered neuroprotectin D1 (AT-NPD1), which activates cell-survival pathways after middle...
16.
Naydenov N, Lechuga S, Zalavadia A, Mukherjee P, Gordon I, Skvasik D, et al.
Cells
. 2022 May;
11(9).
PMID: 35563773
Recurrent chronic mucosal inflammation, a characteristic of inflammatory bowel diseases (IBD), perturbs the intestinal epithelial homeostasis resulting in formation of mucosal wounds and, in most severe cases, leads to colitis-associated...
17.
Cruz Flores V, Menghani H, Mukherjee P, Marrero L, Obenaus A, Dang Q, et al.
Front Pharmacol
. 2021 Oct;
12:746470.
PMID: 34630114
Glioblastoma multiforme (GBM) is an aggressive, highly proliferative, invasive brain tumor with a poor prognosis and low survival rate. The current standard of care for GBM is chemotherapy combined with...
18.
Calandria J, Bhattacharjee S, Maness N, Kautzmann M, Asatryan A, Gordon W, et al.
Sci Rep
. 2021 Jun;
11(1):12324.
PMID: 34112906
The pro-homeostatic lipid mediators elovanoids (ELVs) attenuate cell binding and entrance of the SARS-CoV-2 receptor-binding domain (RBD) as well as of the SARS-CoV-2 virus in human primary alveoli cells in...
19.
Belayev L, Obenaus A, Mukherjee P, Knott E, Khoutorova L, Reid M, et al.
Brain Circ
. 2021 Jan;
6(4):260-268.
PMID: 33506149
Objective: Acute ischemic stroke triggers complex neurovascular, neuroinflammatory, and synaptic alterations. This study explores whether blocking pro-inflammatory platelet-activating factor receptor (PAF-R) plus selected docosanoids after middle cerebral artery occlusion (MCAo)...
20.
Mao R, Doyon G, Gordon I, Li J, Lin S, Wang J, et al.
Gut
. 2021 Jan;
71(1):55-67.
PMID: 33468536
Objective: Creeping fat, the wrapping of mesenteric fat around the bowel wall, is a typical feature of Crohn's disease, and is associated with stricture formation and bowel obstruction. How creeping...